Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Sjöholm T, Korenyushkin A, Gammelgård G, Sarén T, Lövgren T, Loskog A, Essand M, Kullberg J, Enblad G, Ahlström H


Cancer Imaging. 2022 Dec 27

View abstract Share on Linkedin Share on Twitter